Orio Therapeutics originates from the research work of its two co-founders in the field of regenerative medicine and protein engineering. The company is based on a patented technology they developed at Monash University, Australia, allowing them to integrate a "built-in" delivery system for any therapeutic protein. Based on the Swiss roots of the co-founders and the Australian origin of the technology, Orio Therapeutics is taking this opportunity to develop its activities in Monthey and Melbourne. Orio Therapeutics has set as a priority for their first product the development of a cardioprotective drug for heart attack patients (STEMI) .
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
